SIGNOSTICS LAUNCHES USCAN ULTRASOUND DEVICE.
We are very pleased to launch Uscan in the U.S., ensuring access to a new breakthrough in ultrasound technology that goes beyond the functionalities of conventional bladder scanners, said Kevin Goodwin, CEO. Using a small handheld device, Uscan's dual capabilities of providing intelligent visualization coupled with high accuracy allows an enhanced understanding of patient information and more confident point-of-care clinical decision making.
Since its recent FDA clearance, Uscan has been successfully demonstrated at more than 100 hospitals across the country, as well as to physicians attending the American Urological Association's 2016 Annual Meeting, said Ryan Detzel, vice president of sales. Having Uscan units now available in the U.S. allows us to fulfill existing orders and provide evaluation units for customers who wish to test the newest technology in the ultrasound space.
Uscan offers the lowest cost of ownership in the industry: 5-year product warranty with no additional costs for calibration. It is simple to learn and use, and provides real-time user guidance, eliminating the need for extensive training.
Uscan's integrated ultrasound mode is not found in any comparably priced systems, and can be used in a wide range of clinical and diagnostics applications, including urology, the emergency department, maternity, pediatrics, oncology, rehabilitation, aged care and home nursing. The system's removable probe, high-resolution touch screen tablet and handheld displays make it ideally suited for on- the-go clinical care.
Uscan is the world's first advanced ultrasound for bladder care, representing a category breakthrough. Using ultrasound and algorithms from the science of computer vision, Uscan actively recognizes the 3D contours of the bladder, for far more accurate volume measurements than the industry standard* even on obese and other hard-to-scan patients. It acquires up to 256 bladder slices 32 times more than conventional bladder scanners resulting in industry-leading accuracy. Beyond the bladder, Uscan adds unique clinical capacity through real-time ultrasound imaging of the kidneys, pelvic floor, prostate, gallbladder, bladder stones, urological catheter emplacement and pelvic mesh status. It is compatible with Android operating systems, and has built-in WiFi and Bluetooth connectivity that enables fast and reliable image management and interoperability with electronic health record (EHR) systems.
Signostics Inc. is a wholly-owned subsidiary of Signostics Limited, a global medical device manufacturer. Its parent company, Echonous, Inc., is a KKR portfolio company. Signostics is pioneering advanced ultrasound devices for imaging and clinical decision making. The company's flagship product Uscan, is a handheld ultrasound device for bladder care that is embarking on the use of highly miniaturized technology through the science of computer vision. Uscan can also be used to image kidneys, pelvic floor, prostate, gallbladder, bladder stones and urological catheter emplacement. The company has regulatory approvals in the U.S., Europe and Australia, and exports to countries around the world.
For more information, visit www.signosticsmedical.com or call 323/202-1051.
|Printer friendly Cite/link Email Feedback|
|Publication:||Biotech Equipment Update|
|Date:||Sep 1, 2016|
|Previous Article:||STUDY CONFIRMS LUMAGEM'S MBI HIGH CANCER DETECTION.|
|Next Article:||CORINDUS AND ACIST COLLABORATE TO IMPROVE WORKFLOW.|